ERBB3 and colorectal carcinoma: Based on our present results and on previous analyses of primary rectal adenocarcinomas and CRC liver metastases, we found both HER-2 and HER-3 overexpressed in a substantial proportion of CRC [24, 25], and in CRC cell lines.